← All trials
NCT04686175
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 18, 2021
- Primary completion
- Feb 28, 2023
- Completion date
- Mar 31, 2023
- First posted
- Dec 28, 2020
- Last posted
- Sep 23, 2021
- Enrollment
- 9
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Inozyme PharmaLead sponsor
- IQVIACollaborator
- Inozyme PharmaStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.